Pharmacoepidemiology and Drug Safety

Cover image for Vol. 21 Issue 3

March 2012

Volume 21, Issue 3

Pages 233–342

  1. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
    1. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure (pages 233–240)

      Rishi J. Desai, Carol M. Ashton, Anita Deswal, Robert O. Morgan, Hemalkumar B. Mehta, Hua Chen, Rajender R. Aparasu and Michael L. Johnson

      Version of Record online: 22 JUL 2011 | DOI: 10.1002/pds.2175

  2. Commentaries

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
  3. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
    1. Assessing vaccine safety communication with healthcare providers in a large urban county (pages 269–275)

      Dana Meranus, Andy Stergachis, Jenny Arnold and Jeffrey Duchin

      Version of Record online: 28 SEP 2011 | DOI: 10.1002/pds.2245

    2. Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation (pages 276–280)

      Ashok Krishnaswami, Kathleen B. Albers, Robin D. Fross, James J. Jang, Sarah B. Berkheimer, Valerie C. Kwai Ben and Stephen K. VanDenEeden

      Version of Record online: 9 JAN 2012 | DOI: 10.1002/pds.2274

  4. Brief Reports

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
    1. Impact of a health safety warning and prior authorisation on the use of piroxicam: a time-series study (pages 281–284)

      Eduardo Carracedo-Martínez, Agustin Pia-Morandeira and Adolfo Figueiras

      Version of Record online: 10 JAN 2012 | DOI: 10.1002/pds.2275

    2. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006 (pages 285–288)

      Agnès Sommet, Genevieve Durrieu, Maryse Lapeyre-Mestre, Jean-Louis Montastruc and The Association of French PharmacoVigilance Centres

      Version of Record online: 8 DEC 2011 | DOI: 10.1002/pds.2307

  5. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
    1. Influence of socioeconomic factors on the adherence of alendronate treatment in incident users in Norway (pages 297–304)

      Helene M. Devold, Kari Furu, Svetlana Skurtveit, Aage Tverdal, Jan A. Falch and Anne Johanne Sogaard

      Version of Record online: 12 JAN 2012 | DOI: 10.1002/pds.2344

    2. Exposure to inhibitors of the renin–angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case–control study (pages 314–319)

      Guillaume Moulis, Laurent Sailler, Agnès Sommet, Maryse Lapeyre-Mestre, Jean-Louis Montastruc and the French Association of Regional Pharmacovigilance Centers

      Version of Record online: 27 SEP 2011 | DOI: 10.1002/pds.2253

  6. Commentaries

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
  7. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
  8. Letters to the Editor

    1. Top of page
    2. Original Reports
    3. Commentaries
    4. Original Reports
    5. Brief Reports
    6. Original Reports
    7. Commentaries
    8. Original Reports
    9. Letters to the Editor
    1. Reconciling the risk of QT interval prolongation in antidepressants (pages 329–330)

      A. J. Mckean, C. L. Sola, C. Galardy, S. Kung and T. W. Lineberry

      Version of Record online: 8 MAR 2012 | DOI: 10.1002/pds.3216

    2. Additional data on citalopram and the risk of sudden cardiac death and ventricular arrhythmia (pages 331–332)

      Charles E. Leonard, Warren B. Bilker, Craig Newcomb, Stephen E. Kimmel and Sean Hennessy

      Version of Record online: 8 MAR 2012 | DOI: 10.1002/pds.2352

    3. Author's reply (page 335)

      Gloria Manso

      Version of Record online: 8 MAR 2012 | DOI: 10.1002/pds.3201

    4. Response to Teschke et al. (pages 339–340)

      Gail Mahady, Tieraona Low Dog, Nandakumara D. Sarma, James Griffiths and Gabriel I. Giancaspro

      Version of Record online: 8 MAR 2012 | DOI: 10.1002/pds.3210

      Corrected by:

      Erratum: Erratum

      Vol. 21, Issue 7, 787, Version of Record online: 4 JUL 2012

    5. Choosing an appropriate control group for an observational study design (page 341)

      Sjoerd T. Nauta and Ron Van Domburg

      Version of Record online: 8 MAR 2012 | DOI: 10.1002/pds.3215

    6. Reply to Drs. Nauta and van Domburg (page 342)

      Jari Haukka, Leo Niskanen, Timo Partonen, Jouko Lönnqvist and Jari Tiihonen

      Version of Record online: 8 MAR 2012 | DOI: 10.1002/pds.3222

SEARCH

SEARCH BY CITATION